{"lastModified":"2025-04-04T22:00:23","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacja.xsp?typ=int&nr=8517","rel":"web-description"},{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=DEPFL5","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/8517/body","rel":"body"}],"num":8517,"receiptDate":"2025-03-06","term":10,"title":"Interpelacja w sprawie leku Wizil stosowanego w leczeniu choroby Wilsona","answerDelayedDays":0,"from":["469"],"recipientDetails":[{"answerDelayedDays":0,"name":"minister zdrowia","sent":"2025-03-11"}],"replies":[{"attachments":[{"URL":"https://api.sejm.gov.pl/sejm/term10/interpellations/attachment/ATTDFEHPY/i08517-o1.pdf","lastModified":"2025-04-04T22:00:23","name":"i08517-o1.pdf"}],"from":"Podsekretarz stanu Jerzy Szafranowicz","key":"DFEHPY","lastModified":"2025-04-04T22:00:23","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=DFEHPY","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/8517/reply/DFEHPY/body","rel":"body"}],"onlyAttachment":true,"prolongation":false,"receiptDate":"2025-04-03"}],"sentDate":"2025-03-11","to":["minister zdrowia"]}